TY - JOUR
T1 - Total Body Irradiation
T2 - Guidelines from the International Lymphoma Radiation Oncology Group (ILROG)
AU - Wong, Jeffrey Y C
AU - Filippi, Andrea Riccardo
AU - Dabaja, Bouthaina Shbib
AU - Yahalom, Joachim
AU - Specht, Lena
N1 - Copyright © 2018 Elsevier Inc. All rights reserved.
PY - 2018/7/1
Y1 - 2018/7/1
N2 - Total body irradiation (TBI) remains an effective myeloablative treatment in regimens used for preparation and conditioning before allogeneic stem cell transplantation for leukemia. The regimens used vary across institutions in terms of dose, dose rate, fractionation, and technique. The objective of this document is to provide comprehensive guidelines for the current practice of delivering total body irradiation.
AB - Total body irradiation (TBI) remains an effective myeloablative treatment in regimens used for preparation and conditioning before allogeneic stem cell transplantation for leukemia. The regimens used vary across institutions in terms of dose, dose rate, fractionation, and technique. The objective of this document is to provide comprehensive guidelines for the current practice of delivering total body irradiation.
KW - Humans
KW - Internationality
KW - Lymphoma/radiotherapy
KW - Practice Guidelines as Topic
KW - Societies, Medical
KW - Whole-Body Irradiation/instrumentation
U2 - 10.1016/j.ijrobp.2018.04.071
DO - 10.1016/j.ijrobp.2018.04.071
M3 - Review
C2 - 29893272
SN - 0360-3016
VL - 101
SP - 521
EP - 529
JO - International Journal of Radiation Oncology, Biology, Physics
JF - International Journal of Radiation Oncology, Biology, Physics
IS - 3
ER -